HELEX

AcronymDefinition
HELEXHelicopter(ed) Exercise
References in periodicals archive ?
Approved by the FDA in August 2006, the GORE HELEX Septal Occluder was one of two devices discussed.
The study is an FDA approved prospective, randomized, multi-center, international trial designed to demonstrate safety and effectiveness of the GORE HELEX Septal Occluder for PFO closure in patients with a history of cryptogenic stroke or imaging-confirmed transient ischemic attack (TIA).
I have now used the GORE HELEX Device in more than 250 patients with excellent results.
Alternative devices (like the GORE HELEX Septal Occluder) may offer substantial advantages and fewer complications, thereby increasing the differences between device and medical therapy.
The Gore REDUCE Clinical Study is a prospective, randomized, multi-center, multi-national trial designed to demonstrate safety and effectiveness of the GORE HELEX Septal Occluder for (PFO) closure in patients with history of cryptogenic stroke or imaging-confirmed Transient Ischemic Attack (TIA).
Gore & Associates (Gore) today provided an update on the Gore REDUCE Clinical Study*, a prospective, randomized, multi-center, multi-national trial designed to demonstrate safety and effectiveness of the GORE HELEX Septal Occluder for Patent Foramen Ovale (PFO) closure in patients with history of cryptogenic stroke or imaging-confirmed Transient Ischemic Attack (TIA).
Instituto Nacional de Cardiologia was the first in Mexico to offer the GORE HELEX Device to children and adults with an ASD as an alternative to open heart surgery," said Dr.
The GORE HELEX Septal Occluder was approved by the FDA in August 2006 for treatment of ASD, a congenital heart defect.
Caution: GORE HELEX Septal Occluder for the Indication of PFO closure and GORE Embolic Filter are Investigational Devices.
GORE, GORE-TEX([R]), ELIXER([R]), HELEX, inLIGHTEN, and OPTIFADE are trademarks of W.
Gore is conducting other studies in the area of stroke intervention including the Gore REDUCE Clinical Study** evaluating the GORE HELEX Septal Occluder for patent foramen ovale closure and stroke prevention, and the Gore EMBOLDEN Clinical Study*** evaluating the GORE Embolic Filter in CAS.
Multi-National Trial to Demonstrate Safety, Effectiveness of GORE HELEX Septal Occluder for PFO Closure in Patients with a History of Cryptogenic Stroke